Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oxford BioMedica PLC
OXBCurrent price
338 GBX
0 GBX (0.00%)
Last closed
341 GBX
Company
www.oxb.com
ISIN
GB00BDFBVT43
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
355 977 056 GBX
Yield for 12 month
+39.96 %
1Y
3Y
5Y
10Y
15Y
OXB
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. Address: Windrush Court, Oxford, United Kingdom, OX4 6LT
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
33 903.19 GBXP/E ratio
–Dividend Yield
–Current Year
+8 925 679 470 GBX
Last Year
+13 954 778 845 GBX
Current Quarter
+4 633 151 254 GBX
Last Quarter
+4 292 528 216 GBX
Current Year
+3 907 545 384 GBX
Last Year
+6 896 295 788 GBX
Current Quarter
+1 773 193 615 GBX
Last Quarter
+2 186 985 320 GBX
Key Figures OXB
1 year
3 years
5 years
10 years
EBITDA
-69 865 130 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-15.08 %
PEG Ratio
–
Return On Equity TTM
-117.29 %
Wall Street Target Price
33 903.19 GBX
Revenue TTM
89 256 795 GBX
Book Value
0.76 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-38.8 %
Dividend Yield
–
Gross Profit TTM
82 379 539 GBX
Earnings per share
-1.62 GBX
Diluted Eps TTM
-1.62 GBX
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
106.9 %
Profit Margin
-175.89 %
Dividend Analytics OXB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
30.05.2018
Dividend Date
–
Stock Valuation OXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
250
Enterprise Value Revenue
4.0747
Price Sales TTM
3.9882
Enterprise Value EBITDA
-819.7258
Price Book MRQ
4.8253
Financials OXB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OXB
For 52 weeks
163.77 GBX
393.26 GBX
50 Day MA
344.86 GBX
Shares Short Prior Month
–
200 Day MA
260.57 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart